Post-acute rehabilitation is fast-becoming the latest sector from which the NHS in the UK is preparing to retreat. And levels of publicly-paid for rehab elsewhere in Europe are often surprisingly poor.
HBI speaks exclusively to the broker behind a record real estate deal in Europe, after Medical Properties Trust (MPT) sold a 50% stake in its Median Kliniken portfolio in Germany for over €800m.
It is ironic that conferences on best practice in healthcare are dominated by Americans – the people who have the world’s most dysfunctional healthcare system. Israel and Taiwan are much better bets. So how do they do it?
Stripping away M&A and financial things like indebtedness, all for-profit healthcare businesses will succeed or fail based on these three parameters. And all can be measured along them, too.
German and Spanish hospital giant Fresenius Helios saw 10% revenue growth in the first six months of 2018 and nearly the same EBITDA growth. Fresenius group CEO Stephan Sturm says Helios is looking at a third country, and we talk to an analyst about the various M&A opportunities the group has been linked to as well as the outlook in Germany generally.
German rehabilitation giant Median is being put up for sale by its owners Waterland, according to sources. A local healthcare consultant says that, although this is line with a standard private equity exit timeline, a recent reform might make now a particularly good time to sell.
The Saudi Arabian government has released its draft PPP law. We look through the 50-page document which covers foreign ownership, labour laws and real estate, and speak to Colliers International's head of healthcare in MENA who tells us as far as the last of these is concerned, there is a pleasant surprise.
A quiet healthcare revolution is taking place in the Czech Republic. For the first time in almost two decades, providers and payors have reached an agreement on fees without the need for intervention by the Ministry of Health. Healthcare Europa speaks to an operator who says this is great news for private providers and a large step towards the creation of a more open market.
German healthcare giant Fresenius' inpatient rehab business is moving from hospital subsidiary Helios to its service provision and project management subsidiary Vamed in a group-internal acquisition. We talk to Fresenius about the timing and logic of the deal and strategy for both companies going forward.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
